Genetic variation in aryl N-acetyltransferase results in significant differences in the pharmacokinetic and safety profiles of amifampridine (3,4-diaminopyridine) phosphate.
about
Genetic variation in aryl N-acetyltransferase results in significant differences in the pharmacokinetic and safety profiles of amifampridine (3,4-diaminopyridine) phosphate.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Genetic variation in aryl N-ac ...... ,4-diaminopyridine) phosphate.
@ast
Genetic variation in aryl N-ac ...... ,4-diaminopyridine) phosphate.
@en
type
label
Genetic variation in aryl N-ac ...... ,4-diaminopyridine) phosphate.
@ast
Genetic variation in aryl N-ac ...... ,4-diaminopyridine) phosphate.
@en
prefLabel
Genetic variation in aryl N-ac ...... ,4-diaminopyridine) phosphate.
@ast
Genetic variation in aryl N-ac ...... ,4-diaminopyridine) phosphate.
@en
P2093
P2860
P356
P1476
Genetic variation in aryl N-ac ...... ,4-diaminopyridine) phosphate.
@en
P2093
Boyd Hanson
Charles A O'Neill
Donald G Musson
Huiyu Zhou
Laurie Tsuruda
Marvin R Garovoy
Peter E Haroldsen
P2860
P304
P356
10.1002/PRP2.99
P577
2014-12-09T00:00:00Z